4//SEC Filing
EnteroMedics Inc 4
Accession 0001209191-15-080280
CIK 0001371217operating
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 4:21 PM ET
Size
25.3 KB
Accession
0001209191-15-080280
Insider Transaction Report
Form 4
EnteroMedics IncETRM
KNUDSON MARK B
DirectorChrmn, Pres & CEO
Transactions
- Purchase
Common Stock
2015-11-12$0.16/sh+310,000$49,910→ 613,000 total
Holdings
- 57,571(indirect: By Trust)
Common Stock
- 44,131
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common stock (44,131 underlying) - 350,000
Stock Option (right to buy)
Exercise: $2.58From: 2011-03-16Exp: 2021-02-16→ Common Stock (350,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $1.90From: 2012-01-14Exp: 2021-12-14→ Common Stock (200,000 underlying) - 1,292,225
Stock Option (right to buy)
Exercise: $3.35From: 2012-08-10Exp: 2022-07-10→ Common Stock (1,292,225 underlying) - 1,382(indirect: By Trust)
Common Stock
- 6,776
Stock Option (right to buy)
Exercise: $2.76Exp: 2016-04-20→ Common Stock (6,776 underlying) - 33,432
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (33,432 underlying) - 20,833
Stock Option (right to buy)
Exercise: $3.78Exp: 2019-11-18→ Common Stock (20,833 underlying) - 25,902
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (25,902 underlying) - 50,472
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (50,472 underlying) - 25,000
Warrant (common stock right to buy)
Exercise: $2.19→ Common Stock (25,000 underlying) - 350,000
Stock Option (right to buy)
Exercise: $2.67From: 2011-08-12Exp: 2021-07-12→ Common Stock (350,000 underlying) - 225,000
Stock Option (right to buy)
Exercise: $1.11From: 2015-04-09Exp: 2025-03-09→ Common Stock (225,000 underlying) - 3,215(indirect: By Partnership)
Common Stock
- 7,915
Stock Option (right to buy)
Exercise: $2.76Exp: 2015-04-27→ Common Stock (7,915 underlying) - 1,278,730
Stock Option (right to buy)
Exercise: $1.31From: 2013-06-30Exp: 2013-05-31→ Common Stock (1,278,730 underlying)
Footnotes (7)
- [F1]The price reported is the weighted average purchase price for the transaction reported. The purchase prices ranged from $0.15 to $0.18. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range.
- [F2]Options currently 100% vested.
- [F3]Options vest 33% on date noted and thereafter at 1/24th per month.
- [F4]Warrant becomes exercisable 181 days from the date of issuance at close of offering.
- [F5]Warrant expires five years from the date it becomes exercisable.
- [F6]Vests in increments of 1/48th per month, beginning the date shown.
- [F7]The exercise price is the closing price on July 10, 2012, the date the board authorized the grants subject to stockholder approval of the increase in the number of shares available for awards under the incentive plan, which was obtained on September 27, 2012.
Documents
Issuer
EnteroMedics Inc
CIK 0001371217
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001371217
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 4:21 PM ET
- Size
- 25.3 KB